article

Robert-Atterbury-funding-web

New research will tackle the global threat of antimicrobial resistance

Tuesday, 28 January 2025

Experts from the University of Nottingham have received £1.7million in funding to lead a research project to look at developing new treatments for drug-resistant bacterial infections.

Antimicrobial resistance (AMR) is one of the greatest challenges of the 21st century, with projections estimating up to 8 million annual deaths worldwide by 2050 (Lancet, 2024).

This new international research project aims to combat AMR by investigating how resistant bacteria spreads between humans, livestock, and wildlife and will explore innovative treatments to combat this by using bacteriophages - viruses that specifically target and destroy bacteria.

We are approaching a critical point where many of the antimicrobials we have relied upon in the past to treat common infections are becoming ineffective. New antimicrobials entering the market are few and far between, so alternative approaches are urgently needed. We now have the opportunity to develop new treatments for drug-resistant bacterial infections by recruiting their natural enemies, bacteriophages.”
Dr Robert Atterbury, Associate Professor in Microbiology, in the School of Veterinary Medicine and Science at the University of Nottingham

The project, which has been funded by the BBSRC and the Indian Government Department of Biotechnology (DBT), is an international collaboration led by experts at the University of Nottingham, along with colleagues at Loughborough University, the Quadram Institute and the UK Health Security Agency.

Partners in India include the Maharashtra Animal & Fishery Sciences University, the Central India Institute of Medical Science, the National Environmental Engineering Research Institute, the Wildlife Research and Training Center, Nagpur and the University of Delhi.

The collaborative project focuses on Escherichia coli (E. coli), a common source of infection in both humans and animals, and a member of the ESKAPE group of drug-resistant pathogens given high priority by the World Health Organization.

Researchers will study E. coli transmission on farms in the UK and India over a two-year period. This involves sampling livestock and humans, analysing environmental factors, and interviewing farmers to understand management practices that influence the spread of AMR.

To address the growing threat of AMR, the project will also develop a new bacteriophage-based treatment. Bacteriophage (or ‘phage’) are viruses which specifically kill bacteria, including antibiotic-resistant strains. By harnessing artificial intelligence, the team will optimize combinations (or “cocktails”) of bacteriophages to target AMR E. coli strains circulating in livestock and people.

Given the global nature of AMR, where resistant bacteria can spread across borders through international travel and trade, this research highlights the urgent need for worldwide cooperation to tackle the issue.

This groundbreaking project offers hope in the fight against AMR, paving the way for effective, alternative treatments and strategies to protect public and animal health.

Dr Tanya Monaghan, Clinical Associate Professor and Honorary Consultant in Gastroenterology, in the School of Medicine, at Nottingham, said: “AMR has been described as a “catastrophic threat” to human and animal health. As a clinical academic and Gastroenterology consultant, I am acutely aware of the extent of the AMR problem in health care and its association with higher mortality and longer hospitalisation, which is burdening an already overstretched NHS. I am excited to be working on this highly important international interdisciplinary research project and look forward to developing and translating our research findings with our dedicated team of partners.”

Professor Emily Rousham, Professor of Global Public Health at Loughborough University, said: “This is an exciting UK-India collaboration that will allow us to support and improve dairy farming practices in order to reduce the risks of antibiotic resistance developing in livestock and humans.”

Story credits

More information is available from Dr Robert Atterbury, in the School of Veterinary Medicine and Science at robert.atterbury@nottingham.ac.uk

CharlotteAnscombe
Charlotte Wall - Media Relations Manager - Faculty of Medicine and Health Sciences
Email: charlotte.wall@nottingham.ac.uk
Phone: 0115 748 4417
Location:

Notes to editors:

About the University of Nottingham

Ranked 32 in Europe and 16th in the UK by the QS World University Rankings: Europe 2024, the University of Nottingham is a founding member of the Russell Group of research-intensive universities. Studying at the University of Nottingham is a life-changing experience, and we pride ourselves on unlocking the potential of our students. We have a pioneering spirit, expressed in the vision of our founder Sir Jesse Boot, which has seen us lead the way in establishing campuses in China and Malaysia - part of a globally connected network of education, research and industrial engagement.

Nottingham was crowned Sports University of the Year by The Times and Sunday Times Good University Guide 2024 – the third time it has been given the honour since 2018 – and by the Daily Mail University Guide 2024.

The university is among the best universities in the UK for the strength of our research, positioned seventh for research power in the UK according to REF 2021. The birthplace of discoveries such as MRI and ibuprofen, our innovations transform lives and tackle global problems such as sustainable food supplies, ending modern slavery, developing greener transport, and reducing reliance on fossil fuels.

The university is a major employer and industry partner - locally and globally - and our graduates are the second most targeted by the UK's top employers, according to The Graduate Market in 2022 report by High Fliers Research.

We lead the Universities for Nottingham initiative, in partnership with Nottingham Trent University, a pioneering collaboration between the city’s two world-class institutions to improve levels of prosperity, opportunity, sustainability, health and wellbeing for residents in the city and region we are proud to call home.

More news…

Media Relations - External Relations

The University of Nottingham
YANG Fujia Building
Jubilee Campus
Wollaton Road
Nottingham, NG8 1BB

telephone: +44 (0) 115 951 5798
email: pressoffice@nottingham.ac.uk